Detalhe da pesquisa
1.
How I Use Next Generation Sequencing-MRD to Plan Approach and Prevent Relapse after HCT for Children and Adults with ALL.
Blood;
2024 May 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38728375
2.
How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL.
Blood;
141(11): 1251-1264, 2023 03 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36416729
3.
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood;
142(8): 700-710, 2023 08 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37319437
4.
Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study.
J Allergy Clin Immunol;
153(5): 1423-1431.e2, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38290608
5.
KIR-favorable TCR-αß/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial.
Blood;
140(24): 2556-2572, 2022 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35776909
6.
Metabolomic identification of α-ketoglutaric acid elevation in pediatric chronic graft-versus-host disease.
Blood;
139(2): 287-299, 2022 01 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34534280
7.
Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC.
Blood;
140(7): 685-705, 2022 08 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35671392
8.
The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions.
J Allergy Clin Immunol;
151(2): 539-546, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36456361
9.
Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation.
J Allergy Clin Immunol;
151(1): 260-271, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35987350
10.
Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.
J Allergy Clin Immunol;
152(6): 1619-1633.e11, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37659505
11.
The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
J Allergy Clin Immunol;
151(2): 547-555.e5, 2023 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36456360
12.
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
Am J Hematol;
98(4): 608-619, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36606713
13.
Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation.
Pediatr Blood Cancer;
70 Suppl 6: e30577, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37480158
14.
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders.
J Allergy Clin Immunol;
149(3): 1097-1104.e2, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34375618
15.
Granulocyte Transfusions in Patients with Chronic Granulomatous Disease Undergoing Hematopoietic Cell Transplantation or Gene Therapy.
J Clin Immunol;
42(5): 1026-1035, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35445907
16.
Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
Blood;
135(15): 1287-1298, 2020 04 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32047896
17.
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
Blood;
135(23): 2094-2105, 2020 06 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32268350
18.
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
N Engl J Med;
378(5): 439-448, 2018 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29385370
19.
Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Blood;
134(3): 304-316, 2019 07 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31043425
20.
Outcomes after late bone marrow and very early central nervous system relapse of childhood B-acute lymphoblastic leukemia: a report from the Children's Oncology Group phase III study AALL0433.
Haematologica;
106(1): 46-55, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32001530